Menu

Interactive Infographic: State Laws for Medical Aid-in-Dying

In six states and the District of Columbia, terminally ill patients can get a perscription for a life-ending drug, and several additional states are considering legalizing the practice.

Aug 16, 2017
Catherine Offord

Medical aid-in-dying—a physician’s prescription for a lethal dose of a drug to end a patient’s life—is legal for terminally ill patients in six states and the District of Columbia. A further 30 states have been considering legislation on medical aid-in-dying during this year’s legislative session, according to advocacy group Death with Dignity. Euthanasia—the practice of assisting in someone else’s death directly, for example, by physician-administered lethal injection—is currently not legal anywhere in the United States. (Click the labeled states for more information about their practices.)

DEVELOPED BY KARL PAWLOWICZ

Since we developed this map, three additional states have proposed legislation regarding medical aid-in-dying: Oklahoma, New Jersey, and Rhode Island.

See world map for an overview of practices by country.

Correction (August 29): This map has been updated to correctly identify the light orange–shaded states as those considering legislation, while the medium orange states have no proposed legislation. The Scientist regrets the error.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.